Evidence map›Paper›PMID 36908939›Full record

ArticleMedical journal of the Islamic Republic of Iran2022

Policy Implications for Diabetes Prevention and Control: An Experience from Iran.

Niloofar Peykari, Fatemeh Ghaemi, Ensieh Nasli, Ali Reza Mahdavi Hazaveh, Elham Yousefi, Hadi Monji, Mahdi Shadnoush, Farshad Farzadfar, Bagher Larijani

Abstract read
In one paragraph

Article in Medical journal of the Islamic Republic of Iran, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Niloofar PeykariDeputy for Education, Ministry of Health and Medical Education, Tehran, Iran.
Fatemeh GhaemiDeputy for Currative Affaire, Ministry of Health and Medical Education, Tehran, Iran.
Ensieh NasliEndocrinology & Metabolism Research Institute, Tehran university of Medical Sciences, Tehran, Iran.
Ali Reza Mahdavi HazavehDeputy for Health, Ministry of Health and Medical Education, Tehran, Iran.
Elham YousefiDeputy for Health, Ministry of Health and Medical Education, Tehran, Iran.
Hadi MonjiEndocrinology & Metabolism Research Institute, Tehran university of Medical Sciences, Tehran, Iran.
Mahdi ShadnoushDeputy for Currative Affaire, Ministry of Health and Medical Education, Tehran, Iran.
Farshad FarzadfarEndocrinology & Metabolism Research Institute, Tehran university of Medical Sciences, Tehran, Iran.
Bagher LarijaniDepartment of Internal Medicine, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran.ORCID https://orcid.org/0000-0001-5386-7597

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

DiabetesIranPolicy

Identifiers

PMID36908939
PMCPMC9997414

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.